Chartwell Investment Partners, LLC Collegium Pharmaceutical, Inc Transaction History

Chartwell Investment Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$15.78 - $20.82 $600,381 - $792,138	-38,047 Closed	0 $0
Q2 2020 Jul 29, 2020	BUY	$15.49 - $23.51 $589,348 - $894,484	38,047 New	38,047 $666,000
Q3 2018 Nov 08, 2018	SELL	$14.16 - $24.3 $1.43 Million - $2.45 Million	-100,704 Closed	0 $0
Q2 2018 Aug 09, 2018	SELL	$21.79 - $28.29 $1.82 Million - $2.37 Million	-83,633 Reduced 45.37%	100,704 $2.4 Million
Q1 2018 May 08, 2018	BUY	$18.15 - $29.21 $46,064 - $74,134	2,538 Added 1.4%	184,337 $3.4 Million
Q1 2018 May 08, 2018	SELL	$18.15 - $29.21 $46,064 - $74,134	-2,538 Reduced 1.38%	181,799 $4.65 Million
Q4 2017 Feb 08, 2018	BUY	$9.3 - $19.14 $1.71 Million - $3.53 Million	184,337	184,337 $3.4 Million

253

37.1M

61.1K

5.8K

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

Get notified when there are updates to the investment portfolio of Chartwell Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Chartwell Investment Partners, LLC with notifications on news.